MC
UTHR icon

Maverick Capital’s United Therapeutics UTHR Stock Holding History

Maverick Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,361
Closed -$805K – 620
2021
Q3 		$805K Sell
4,361
-3,992
-48% -$786K 0.01% 364
2021
Q2 		$1.5M Buy
8,353
+839
+11% +$160K 0.01% 200
2021
Q1 		$1.26M Buy
+7,514
New +$1.25M 0.01% 212
2020
Q1 		– Sell
-14,781
Closed -$1.3M – 547
2019
Q4 		$1.3M Buy
14,781
+2,019
+16% +$178K 0.02% 301
2019
Q3 		$1.02M Buy
+12,762
New +$1.03M 0.02% 278
2017
Q3 		– Sell
-18,720
Closed -$2.43M – 223
2017
Q2 		$2.43M Sell
18,720
-720
-4% -$89.8K 0.03% 115
2017
Q1 		$2.63M Sell
19,440
-6,770
-26% -$1.03M 0.03% 89
2016
Q4 		$3.76M Buy
26,210
+300
+1% +$38.3K 0.05% 32
2016
Q3 		$3.06M Sell
25,910
-800
-3% -$96.1K 0.04% 69
2016
Q2 		$2.83M Buy
26,710
+5,780
+28% +$645K 0.04% 68
2016
Q1 		$2.33M Buy
20,930
+10,360
+98% +$1.31M 0.04% 65
2015
Q4 		$1.66M Buy
10,570
+930
+10% +$135K 0.02% 44
2015
Q3 		$1.26M Buy
9,640
+5,870
+156% +$941K 0.02% 55
2015
Q2 		$656K Sell
3,770
-730
-16% -$131K 0.01% 52
2015
Q1 		$776K Buy
+4,500
New +$686K 0.01% 40

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Maverick Capital's UTHR Position: Q4 2021 in Review

Maverick Capital sold out of United Therapeutics (UTHR) in Q4 2021, closing a stake of 4,361 shares — an estimated $805K sold.

Maverick Capital first reported a position in UTHR in Q1 2015 and held it in 15 quarters. The position peaked at $3.76M in Q4 2016. 416 funds tracked by Wall St. Rank hold UTHR as of Q4 2021.

  • Maverick Capital reported no remaining United Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Maverick Capital sold 4,361 United Therapeutics shares in Q4 2021, an estimated $805K.
  • Maverick Capital first reported a position in United Therapeutics in Q1 2015 and held it in 15 quarters.
  • Maverick Capital's United Therapeutics position peaked at $3.76M in Q4 2016.
  • 416 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2021.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.